Drug intelligence / Profile preview

combination nicotine replacement therapy (Iowa City VA Health Care System)

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Transdermal, Buccal, Sublingual
01

Overview

Combination nicotine replacement therapy (combination NRT) is a pharmacological strategy for tobacco cessation that involves the simultaneous use of two or more nicotine replacement products. This approach typically pairs a long-acting delivery method, such as a transdermal nicotine patch, with a short-acting form, such as nicotine gum, lozenges, or nasal spray. The transdermal patch provides a steady, baseline level of nicotine to mitigate background withdrawal symptoms, while the short-acting products are used as needed to manage acute cravings or high-risk situations. By addressing both tonic and episodic cravings, combination NRT has been shown to be more effective than single-product NRT monotherapy. The active ingredient is medicinal nicotine, which acts as an agonist at nicotinic acetylcholine receptors (nAChRs) in the brain, mimicking the effects of nicotine from tobacco to reduce withdrawal distress.

Brand names
Nicoderm CQNicoretteHabitrolNicotrol
Other names
combination NRTdual NRTpatch plus gumpatch plus lozenge
02

Targets

α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)CHRNA7 (α7 nicotinic receptor)

Beyond the preview

Go deeper on combination nicotine replacement therapy (Iowa City VA Health Care System).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on combination nicotine replacement therapy (Iowa City VA Health Care System).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call